Investigation of proven vaccine breakthrough by SARS-CoV-2 variants in established UK healthcare worker cohorts: SIREN consortium & PITCH Plus Pathway

Medicine & Life Sciences

1. Severe Acute Respiratory Syndrome 100%
2. Coronavirus 97%
3. Immune System Diseases 82%
4. Vaccination 62%
5. T-Lymphocytes 31%
6. Transplant Recipients 24%
7. Renal Dialysis 22%
8. Vaccines 19%
9. Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 18%
10. Coronavirus Infections 18%
11. Transplants 16%
12. Rituximab 14%
13. Hematopoietic Stem Cell Transplantation 13%
14. Liver Transplantation 11%
15. Anti-Idiotypic Antibodies 10%
16. Immunosuppressive Agents 10%
17. Hospitalization 9%
18. Phenotype 7%
19. Antibodies 7%
20. Infections 6%